There were 855 press releases posted in the last 24 hours and 166,796 in the last 365 days.

Global Inflammatory Bowel Disease (IBD) Therapeutics Industry

Inflammatory Bowel Disease (IBD) Therapeutics market worldwide is projected to grow by US$1. 1 Billion, driven by a compounded growth of 2. 3%. Biologic Therapies, one of the segments analyzed and sized in this study, displays the potential to grow at over 2.

/EIN News/ -- New York, Oct. 11, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Inflammatory Bowel Disease (IBD) Therapeutics Industry" - https://www.reportlinker.com/p05817998/?utm_source=GNW
1%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$4.3 Billion by the year 2025, Biologic Therapies will bring in healthy gains adding significant momentum to global growth.

- Representing the developed world, the United States will maintain a 1.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$44.8 Million to the region’s size and clout in the next 5 to 6 years. Over US$33.3 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Biologic Therapies will reach a market size of US$267.2 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 3.6% over the next couple of years and add approximately US$317.7 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, 4SC AG; Abbott Nutrition; AbbVie, Inc.; Ablynx NV; Active Biotech AB; Alfasigma S.p.A.; Allergan PLC; Allergan PLC; Amgen, Inc.; Astellas Pharma, Inc.; AstraZeneca PLC; Athersys, Inc.; Atlantic Healthcare plc; Avaxia Biologics, Inc.; Biosafe Systems, LLC; Boehringer Ingelheim GmbH; Cadila Healthcare Ltd.; Celgene Corporation; Celltrion, Inc.; Cipla Ltd.; Coherus Biosciences, Inc.; Cosmo Pharmaceuticals NV; Dr. Falk Pharma GmbH; EA Pharma Co., Ltd.; Eddingpharm; EPIRUS Biopharmaceuticals, Inc.; F. Hoffmann-La Roche AG; F. Hoffmann-La Roche AG; Galapagos NV; Giaconda Ltd.; Google LLC; Immunic, Inc.; InDex Pharmaceuticals Holding AB; Infinity Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; Janssen Biotech, Inc.; Johnson & Johnson; Kissei Pharmaceutical Co., Ltd.; LG Sciences; Lupin Ltd.; Mochida Pharmaceutical Co., Ltd.; Mylan Pharmaceutical Pvt. Ltd.; Neovacs SA; Nogra Pharma Limited; NovaMedica LLC; Novartis International AG; Osiris Therapeutics, Inc.; Otsuka Pharmaceutical Co., Ltd.; PAR Pharmaceutical Companies, Inc.; PendoPharm, Inc.; Perrigo Company PLC; Pfenex, Inc.; Pfizer, Inc.; Pharmascience Inc.; Pluristem Therapeutics, Inc.; Qu Biologics Inc.; Quest Diagnostics, Inc.; RedHill Biopharma Ltd.; Reliance Life Sciences; Salix Pharmaceuticals, Inc.; Sandoz International GmbH; Sanofi; Sequella, Inc.; Soligenix, Inc.; Takeda Pharmaceutical Co., Ltd.; Teva Pharmaceutical Industries Ltd.; Toray Industries, Inc.; Torrent Pharmaceuticals Ltd.; UCB SA; Zeria Pharmaceutical Co., Ltd.


Read the full report: https://www.reportlinker.com/p05817998/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Inflammatory Bowel Disease (IBD) Therapeutics Competitor Market
Share Scenario Worldwide (in %): 2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Inflammatory Bowel Disease (IBD) Therapeutics Global
Market Estimates and Forecasts in US$ Million by
Region/Country: 2018-2025
Table 2: Inflammatory Bowel Disease (IBD) Therapeutics Global
Retrospective Market Scenario in US$ Million by Region/Country:
2009-2017
Table 3: Inflammatory Bowel Disease (IBD) Therapeutics Market
Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS
2025
Table 4: Biologic Therapies (Drug Type) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 5: Biologic Therapies (Drug Type) Historic Market
Analysis by Region/Country in US$ Million: 2009 to 2017
Table 6: Biologic Therapies (Drug Type) Market Share Breakdown
of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: Aminosalicylates (Drug Type) Potential Growth Markets
Worldwide in US$ Million: 2018 to 2025
Table 8: Aminosalicylates (Drug Type) Historic Market
Perspective by Region/Country in US$ Million: 2009 to 2017
Table 9: Aminosalicylates (Drug Type) Market Sales Breakdown by
Region/Country in Percentage: 2009 VS 2019 VS 2025
Table 10: Antibiotics (Drug Type) Geographic Market Spread
Worldwide in US$ Million: 2018 to 2025
Table 11: Antibiotics (Drug Type) Region Wise Breakdown of
Global Historic Demand in US$ Million: 2009 to 2017
Table 12: Antibiotics (Drug Type) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 13: Corticosteroids (Drug Type) World Market Estimates
and Forecasts by Region/Country in US$ Million: 2018 to 2025
Table 14: Corticosteroids (Drug Type) Market Historic Review by
Region/Country in US$ Million: 2009 to 2017
Table 15: Corticosteroids (Drug Type) Market Share Breakdown by
Region/Country: 2009 VS 2019 VS 2025
Table 16: Immunomodulators (Drug Type) World Market by
Region/Country in US$ Million: 2018 to 2025
Table 17: Immunomodulators (Drug Type) Historic Market Analysis
by Region/Country in US$ Million: 2009 to 2017
Table 18: Immunomodulators (Drug Type) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Inflammatory Bowel Disease (IBD) Therapeutics Market Share
(in %) by Company: 2019 & 2025
Table 19: United States Inflammatory Bowel Disease (IBD)
Therapeutics Market Estimates and Projections in US$ Million by
Drug Type: 2018 to 2025
Table 20: Inflammatory Bowel Disease (IBD) Therapeutics Market
in the United States by Drug Type: A Historic Review in US$
Million for 2009-2017
Table 21: United States Inflammatory Bowel Disease (IBD)
Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019
VS 2025
CANADA
Table 22: Canadian Inflammatory Bowel Disease (IBD)
Therapeutics Market Estimates and Forecasts in US$ Million by
Drug Type: 2018 to 2025
Table 23: Canadian Inflammatory Bowel Disease (IBD)
Therapeutics Historic Market Review by Drug Type in US$
Million: 2009-2017
Table 24: Inflammatory Bowel Disease (IBD) Therapeutics Market
in Canada: Percentage Share Breakdown of Sales by Drug Type for
2009, 2019, and 2025
JAPAN
Table 25: Japanese Market for Inflammatory Bowel Disease (IBD)
Therapeutics: Annual Sales Estimates and Projections in US$
Million by Drug Type for the Period 2018-2025
Table 26: Inflammatory Bowel Disease (IBD) Therapeutics Market
in Japan: Historic Sales Analysis in US$ Million by Drug Type
for the Period 2009-2017
Table 27: Japanese Inflammatory Bowel Disease (IBD)
Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019
VS 2025
CHINA
Table 28: Chinese Inflammatory Bowel Disease (IBD) Therapeutics
Market Growth Prospects in US$ Million by Drug Type for the
Period 2018-2025
Table 29: Inflammatory Bowel Disease (IBD) Therapeutics
Historic Market Analysis in China in US$ Million by Drug Type:
2009-2017
Table 30: Chinese Inflammatory Bowel Disease (IBD) Therapeutics
Market by Drug Type: Percentage Breakdown of Sales for 2009,
2019, and 2025
EUROPE
Market Facts & Figures
European Inflammatory Bowel Disease (IBD) Therapeutics Market:
Competitor Market Share Scenario (in %) for 2019 & 2025
Table 31: European Inflammatory Bowel Disease (IBD)
Therapeutics Market Demand Scenario in US$ Million by
Region/Country: 2018-2025
Table 32: Inflammatory Bowel Disease (IBD) Therapeutics Market
in Europe: A Historic Market Perspective in US$ Million by
Region/Country for the Period 2009-2017
Table 33: European Inflammatory Bowel Disease (IBD)
Therapeutics Market Share Shift by Region/Country: 2009 VS 2019
VS 2025
Table 34: European Inflammatory Bowel Disease (IBD)
Therapeutics Market Estimates and Forecasts in US$ Million by
Drug Type: 2018-2025
Table 35: Inflammatory Bowel Disease (IBD) Therapeutics Market
in Europe in US$ Million by Drug Type: A Historic Review for
the Period 2009-2017
Table 36: European Inflammatory Bowel Disease (IBD)
Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019
VS 2025
FRANCE
Table 37: Inflammatory Bowel Disease (IBD) Therapeutics Market
in France by Drug Type: Estimates and Projections in US$
Million for the Period 2018-2025
Table 38: French Inflammatory Bowel Disease (IBD) Therapeutics
Historic Market Scenario in US$ Million by Drug Type: 2009-2017
Table 39: French Inflammatory Bowel Disease (IBD) Therapeutics
Market Share Analysis by Drug Type: 2009 VS 2019 VS 2025
GERMANY
Table 40: Inflammatory Bowel Disease (IBD) Therapeutics Market
in Germany: Recent Past, Current and Future Analysis in US$
Million by Drug Type for the Period 2018-2025
Table 41: German Inflammatory Bowel Disease (IBD) Therapeutics
Historic Market Analysis in US$ Million by Drug Type: 2009-2017
Table 42: German Inflammatory Bowel Disease (IBD) Therapeutics
Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025
ITALY
Table 43: Italian Inflammatory Bowel Disease (IBD) Therapeutics
Market Growth Prospects in US$ Million by Drug Type for the
Period 2018-2025
Table 44: Inflammatory Bowel Disease (IBD) Therapeutics
Historic Market Analysis in Italy in US$ Million by Drug Type:
2009-2017
Table 45: Italian Inflammatory Bowel Disease (IBD) Therapeutics
Market by Drug Type: Percentage Breakdown of Sales for 2009,
2019, and 2025
UNITED KINGDOM
Table 46: United Kingdom Market for Inflammatory Bowel Disease
(IBD) Therapeutics: Annual Sales Estimates and Projections in
US$ Million by Drug Type for the Period 2018-2025
Table 47: Inflammatory Bowel Disease (IBD) Therapeutics Market
in the United Kingdom: Historic Sales Analysis in US$ Million
by Drug Type for the Period 2009-2017
Table 48: United Kingdom Inflammatory Bowel Disease (IBD)
Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019
VS 2025
SPAIN
Table 49: Spanish Inflammatory Bowel Disease (IBD) Therapeutics
Market Estimates and Forecasts in US$ Million by Drug Type:
2018 to 2025
Table 50: Spanish Inflammatory Bowel Disease (IBD) Therapeutics
Historic Market Review by Drug Type in US$ Million: 2009-2017
Table 51: Inflammatory Bowel Disease (IBD) Therapeutics Market
in Spain: Percentage Share Breakdown of Sales by Drug Type for
2009, 2019, and 2025
RUSSIA
Table 52: Russian Inflammatory Bowel Disease (IBD) Therapeutics
Market Estimates and Projections in US$ Million by Drug Type:
2018 to 2025
Table 53: Inflammatory Bowel Disease (IBD) Therapeutics Market
in Russia by Drug Type: A Historic Review in US$ Million for
2009-2017
Table 54: Russian Inflammatory Bowel Disease (IBD) Therapeutics
Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 55: Rest of Europe Inflammatory Bowel Disease (IBD)
Therapeutics Market Estimates and Forecasts in US$ Million by
Drug Type: 2018-2025
Table 56: Inflammatory Bowel Disease (IBD) Therapeutics Market
in Rest of Europe in US$ Million by Drug Type: A Historic
Review for the Period 2009-2017
Table 57: Rest of Europe Inflammatory Bowel Disease (IBD)
Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019
VS 2025
ASIA-PACIFIC
Table 58: Asia-Pacific Inflammatory Bowel Disease (IBD)
Therapeutics Market Estimates and Forecasts in US$ Million by
Region/Country: 2018-2025
Table 59: Inflammatory Bowel Disease (IBD) Therapeutics Market
in Asia-Pacific: Historic Market Analysis in US$ Million by
Region/Country for the Period 2009-2017
Table 60: Asia-Pacific Inflammatory Bowel Disease (IBD)
Therapeutics Market Share Analysis by Region/Country: 2009 VS
2019 VS 2025
Table 61: Inflammatory Bowel Disease (IBD) Therapeutics Market
in Asia-Pacific by Drug Type: Estimates and Projections in US$
Million for the Period 2018-2025
Table 62: Asia-Pacific Inflammatory Bowel Disease (IBD)
Therapeutics Historic Market Scenario in US$ Million by Drug
Type: 2009-2017
Table 63: Asia-Pacific Inflammatory Bowel Disease (IBD)
Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019
VS 2025
AUSTRALIA
Table 64: Inflammatory Bowel Disease (IBD) Therapeutics Market
in Australia: Recent Past, Current and Future Analysis in US$
Million by Drug Type for the Period 2018-2025
Table 65: Australian Inflammatory Bowel Disease (IBD)
Therapeutics Historic Market Analysis in US$ Million by Drug
Type: 2009-2017
Table 66: Australian Inflammatory Bowel Disease (IBD)
Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019
VS 2025
INDIA
Table 67: Indian Inflammatory Bowel Disease (IBD) Therapeutics
Market Estimates and Forecasts in US$ Million by Drug Type:
2018 to 2025
Table 68: Indian Inflammatory Bowel Disease (IBD) Therapeutics
Historic Market Review by Drug Type in US$ Million: 2009-2017
Table 69: Inflammatory Bowel Disease (IBD) Therapeutics Market
in India: Percentage Share Breakdown of Sales by Drug Type for
2009, 2019, and 2025
SOUTH KOREA
Table 70: Inflammatory Bowel Disease (IBD) Therapeutics Market
in South Korea: Recent Past, Current and Future Analysis in US$
Million by Drug Type for the Period 2018-2025
Table 71: South Korean Inflammatory Bowel Disease (IBD)
Therapeutics Historic Market Analysis in US$ Million by Drug
Type: 2009-2017
Table 72: Inflammatory Bowel Disease (IBD) Therapeutics Market
Share Distribution in South Korea by Drug Type: 2009 VS 2019 VS
2025
REST OF ASIA-PACIFIC
Table 73: Rest of Asia-Pacific Market for Inflammatory Bowel
Disease (IBD) Therapeutics: Annual Sales Estimates and
Projections in US$ Million by Drug Type for the Period
2018-2025
Table 74: Inflammatory Bowel Disease (IBD) Therapeutics Market
in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million
by Drug Type for the Period 2009-2017
Table 75: Rest of Asia-Pacific Inflammatory Bowel Disease (IBD)
Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019
VS 2025
LATIN AMERICA
Table 76: Latin American Inflammatory Bowel Disease (IBD)
Therapeutics Market Trends by Region/Country in US$ Million:
2018-2025
Table 77: Inflammatory Bowel Disease (IBD) Therapeutics Market
in Latin America in US$ Million by Region/Country: A Historic
Perspective for the Period 2009-2017
Table 78: Latin American Inflammatory Bowel Disease (IBD)
Therapeutics Market Percentage Breakdown of Sales by
Region/Country: 2009, 2019, and 2025
Table 79: Latin American Inflammatory Bowel Disease (IBD)
Therapeutics Market Growth Prospects in US$ Million by Drug
Type for the Period 2018-2025
Table 80: Inflammatory Bowel Disease (IBD) Therapeutics
Historic Market Analysis in Latin America in US$ Million by
Drug Type: 2009-2017
Table 81: Latin American Inflammatory Bowel Disease (IBD)
Therapeutics Market by Drug Type: Percentage Breakdown of
Sales for 2009, 2019, and 2025
ARGENTINA
Table 82: Argentinean Inflammatory Bowel Disease (IBD)
Therapeutics Market Estimates and Forecasts in US$ Million by
Drug Type: 2018-2025
Table 83: Inflammatory Bowel Disease (IBD) Therapeutics Market
in Argentina in US$ Million by Drug Type: A Historic Review for
the Period 2009-2017
Table 84: Argentinean Inflammatory Bowel Disease (IBD)
Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019
VS 2025
BRAZIL
Table 85: Inflammatory Bowel Disease (IBD) Therapeutics Market
in Brazil by Drug Type: Estimates and Projections in US$
Million for the Period 2018-2025
Table 86: Brazilian Inflammatory Bowel Disease (IBD)
Therapeutics Historic Market Scenario in US$ Million by Drug
Type: 2009-2017
Table 87: Brazilian Inflammatory Bowel Disease (IBD)
Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019
VS 2025
MEXICO
Table 88: Inflammatory Bowel Disease (IBD) Therapeutics Market
in Mexico: Recent Past, Current and Future Analysis in US$
Million by Drug Type for the Period 2018-2025
Table 89: Mexican Inflammatory Bowel Disease (IBD) Therapeutics
Historic Market Analysis in US$ Million by Drug Type: 2009-2017
Table 90: Mexican Inflammatory Bowel Disease (IBD) Therapeutics
Market Share Breakdown by Drug Type: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 91: Rest of Latin America Inflammatory Bowel Disease
(IBD) Therapeutics Market Estimates and Projections in US$
Million by Drug Type: 2018 to 2025
Table 92: Inflammatory Bowel Disease (IBD) Therapeutics Market
in Rest of Latin America by Drug Type: A Historic Review in US$
Million for 2009-2017
Table 93: Rest of Latin America Inflammatory Bowel Disease
(IBD) Therapeutics Market Share Breakdown by Drug Type: 2009 VS
2019 VS 2025
MIDDLE EAST
Table 94: The Middle East Inflammatory Bowel Disease (IBD)
Therapeutics Market Estimates and Forecasts in US$ Million by
Region/Country: 2018-2025
Table 95: Inflammatory Bowel Disease (IBD) Therapeutics Market
in the Middle East by Region/Country in US$ Million: 2009-2017
Table 96: The Middle East Inflammatory Bowel Disease (IBD)
Therapeutics Market Share Breakdown by Region/Country: 2009,
2019, and 2025
Table 97: The Middle East Inflammatory Bowel Disease (IBD)
Therapeutics Market Estimates and Forecasts in US$ Million by
Drug Type: 2018 to 2025
Table 98: The Middle East Inflammatory Bowel Disease (IBD)
Therapeutics Historic Market by Drug Type in US$ Million:
2009-2017
Table 99: Inflammatory Bowel Disease (IBD) Therapeutics Market
in the Middle East: Percentage Share Breakdown of Sales by
Drug Type for 2009, 2019, and 2025
IRAN
Table 100: Iranian Market for Inflammatory Bowel Disease (IBD)
Therapeutics: Annual Sales Estimates and Projections in US$
Million by Drug Type for the Period 2018-2025
Table 101: Inflammatory Bowel Disease (IBD) Therapeutics Market
in Iran: Historic Sales Analysis in US$ Million by Drug Type
for the Period 2009-2017
Table 102: Iranian Inflammatory Bowel Disease (IBD)
Therapeutics Market Share Analysis by Drug Type: 2009 VS 2019
VS 2025
ISRAEL
Table 103: Israeli Inflammatory Bowel Disease (IBD)
Therapeutics Market Estimates and Forecasts in US$ Million by
Drug Type: 2018-2025
Table 104: Inflammatory Bowel Disease (IBD) Therapeutics Market
in Israel in US$ Million by Drug Type: A Historic Review for
the Period 2009-2017
Table 105: Israeli Inflammatory Bowel Disease (IBD)
Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019
VS 2025
SAUDI ARABIA
Table 106: Saudi Arabian Inflammatory Bowel Disease (IBD)
Therapeutics Market Growth Prospects in US$ Million by Drug
Type for the Period 2018-2025
Table 107: Inflammatory Bowel Disease (IBD) Therapeutics
Historic Market Analysis in Saudi Arabia in US$ Million by Drug
Type: 2009-2017
Table 108: Saudi Arabian Inflammatory Bowel Disease (IBD)
Therapeutics Market by Drug Type: Percentage Breakdown of Sales
for 2009, 2019, and 2025
UNITED ARAB EMIRATES
Table 109: Inflammatory Bowel Disease (IBD) Therapeutics Market
in the United Arab Emirates: Recent Past, Current and Future
Analysis in US$ Million by Drug Type for the Period 2018-2025
Table 110: United Arab Emirates Inflammatory Bowel Disease
(IBD) Therapeutics Historic Market Analysis in US$ Million by
Drug Type: 2009-2017
Table 111: Inflammatory Bowel Disease (IBD) Therapeutics Market
Share Distribution in United Arab Emirates by Drug Type: 2009
VS 2019 VS 2025
REST OF MIDDLE EAST
Table 112: Inflammatory Bowel Disease (IBD) Therapeutics Market
in Rest of Middle East: Recent Past, Current and Future
Analysis in US$ Million by Drug Type for the Period 2018-2025
Table 113: Rest of Middle East Inflammatory Bowel Disease (IBD)
Therapeutics Historic Market Analysis in US$ Million by Drug
Type: 2009-2017
Table 114: Rest of Middle East Inflammatory Bowel Disease (IBD)
Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019
VS 2025
AFRICA
Table 115: African Inflammatory Bowel Disease (IBD)
Therapeutics Market Estimates and Projections in US$ Million by
Drug Type: 2018 to 2025
Table 116: Inflammatory Bowel Disease (IBD) Therapeutics Market
in Africa by Drug Type: A Historic Review in US$ Million for
2009-2017
Table 117: African Inflammatory Bowel Disease (IBD)
Therapeutics Market Share Breakdown by Drug Type: 2009 VS 2019
VS 2025

IV. COMPETITION

4SC AG
ABBOTT NUTRITION
ABBVIE
ABLYNX NV
ACTIVE BIOTECH AB
ALFASIGMA S.P.A.
ALLERGAN PLC
AMGEN
ASTELLAS PHARMA
ASTRAZENECA PLC
ATHERSYS
ATLANTIC HEALTHCARE PLC
AVAXIA BIOLOGICS, INC.
BIOSAFE SYSTEMS, LLC
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
CADILA HEALTHCARE
CELGENE CORPORATION
CELLTRION, INC.
CIPLA
COHERUS BIOSCIENCES , INC.
COSMO PHARMACEUTICALS NV
DR. FALK PHARMA GMBH
EA PHARMA CO., LTD.
EPIRUS BIOPHARMACEUTICALS INC.
F. HOFFMANN-LA ROCHE AG
GALAPAGOS NV
GIACONDA LTD.
GOOGLE LLC
IMMUNIC, INC.
INDEX PHARMACEUTICALS HOLDING AB
INFINITY PHARMACEUTICALS, INC.
IONIS PHARMACEUTICALS, INC.
JANSSEN BIOTECH
JOHNSON & JOHNSON
KISSEI PHARMACEUTICAL
LG SCIENCES
LUPIN
MOCHIDA PHARMACEUTICAL
MYLAN PHARMACEUTICAL PVT.
NEOVACS SA
NOGRA PHARMA LIMITED
NOVAMEDICA LLC
NOVARTIS INTERNATIONAL AG
OSIRIS THERAPEUTICS
OTSUKA PHARMACEUTICAL
PAR PHARMACEUTICAL COMPANIES
PENDOPHARM, INC.
PERRIGO CO., PLC
PFENEX, INC.
PFIZER
PHARMASCIENCE INC.
PLURISTEM THERAPEUTICS, INC.
QU BIOLOGICS INC.
QUEST DIAGNOSTICS
REDHILL BIOPHARMA LTD.
RELIANCE LIFE SCIENCES
SALIX PHARMACEUTICALS
SANDOZ INTERNATIONAL GMBH
SANOFI
SEQUELLA, INC.
SOLIGENIX
TAKEDA PHARMACEUTICAL COMPANY LIMITED
TEVA PHARMACEUTICAL INDUSTRIES
TORAY INDUSTRIES
TORRENT PHARMACEUTICALS
UCB SA
ZERIA PHARMACEUTICAL CO., LTD.

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05817998/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
Distribution channels: Media, Advertising & PR


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.